Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

A Prospective, Multi-centered Study to Assess the Complication Rates of Oncology Patients Accessed With Peripheral Intravenous Lines Versus Implantable Ports for Chemotherapy Administration

This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.

Inclusion Criteria:

• Male or female, age ≥ 21 years
• Subject is currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distally-valved catheter/open-ended catheter or infusion through a PIV
• Subject had a chemotherapy regimen consisting of a vesicant and/or irritant
• Subject has signed an Informed Consent Form (ICF) or has had an ICF signed by the subject's legally authorized representative

Exclusion Criteria:

• Subject has/had an implanted non Bard PORT